PURPOSE: The purpose of this study was to determine whether diabetes type 2 causes thinning of retinal layers as a sign of neurodegeneration and to investigate the possible relationship between this thinning and duration of diabetes mellitus, diabetic retinopathy (DR) status, age, sex, and glycemic control (HbA1c). METHODS: Mean layer thickness was calculated for retinal layers following automated segmentation of spectral domain optical coherence tomography images of diabetic patients with no or minimal DR and compared with controls. To determine the relationship between layer thickness and diabetes duration, DR status, age, sex, and HbA1c, a multiple linear regression analysis was used. RESULTS: In the pericentral area of the macula, the retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), and inner plexiform layer (IPL) were thinner in patients with minimal DR compared to controls (respective difference 1.9 μm, 95% confidence interval [CI] 0.3-3.5 μm; 5.2 μm, 95% CI 1.0-9.3 μm; 4.5 μm, 95% CI 2.2-6.7 μm). In the peripheral area of the macula, the RNFL and IPL were thinner in patients with minimal DR compared to controls (respective difference 3.2 μm, 95% CI 0.1-6.4 μm; 3.3 μm, 95% CI 1.2-5.4 μm). Multiple linear regression analysis showed DR status to be the only significant explanatory variable (R = 0.31, P = 0.03) for this retinal thinning. CONCLUSIONS: This study demonstrated thinner inner retinal layers in the macula of type 2 diabetic patients with minimal DR than in controls. These results support the concept that early DR includes a neurodegenerative component.
PURPOSE: The purpose of this study was to determine whether diabetes type 2 causes thinning of retinal layers as a sign of neurodegeneration and to investigate the possible relationship between this thinning and duration of diabetes mellitus, diabetic retinopathy (DR) status, age, sex, and glycemic control (HbA1c). METHODS: Mean layer thickness was calculated for retinal layers following automated segmentation of spectral domain optical coherence tomography images of diabeticpatients with no or minimal DR and compared with controls. To determine the relationship between layer thickness and diabetes duration, DR status, age, sex, and HbA1c, a multiple linear regression analysis was used. RESULTS: In the pericentral area of the macula, the retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), and inner plexiform layer (IPL) were thinner in patients with minimal DR compared to controls (respective difference 1.9 μm, 95% confidence interval [CI] 0.3-3.5 μm; 5.2 μm, 95% CI 1.0-9.3 μm; 4.5 μm, 95% CI 2.2-6.7 μm). In the peripheral area of the macula, the RNFL and IPL were thinner in patients with minimal DR compared to controls (respective difference 3.2 μm, 95% CI 0.1-6.4 μm; 3.3 μm, 95% CI 1.2-5.4 μm). Multiple linear regression analysis showed DR status to be the only significant explanatory variable (R = 0.31, P = 0.03) for this retinal thinning. CONCLUSIONS: This study demonstrated thinner inner retinal layers in the macula of type 2 diabeticpatients with minimal DR than in controls. These results support the concept that early DR includes a neurodegenerative component.
Authors: A J Barber; M Nakamura; E B Wolpert; C E Reiter; G M Seigel; D A Antonetti; T W Gardner Journal: J Biol Chem Date: 2001-07-06 Impact factor: 5.157
Authors: David A Antonetti; Alistair J Barber; Sarah K Bronson; Willard M Freeman; Thomas W Gardner; Leonard S Jefferson; Mark Kester; Scot R Kimball; J Kyle Krady; Kathryn F LaNoue; Christopher C Norbury; Patrick G Quinn; Lakshman Sandirasegarane; Ian A Simpson Journal: Diabetes Date: 2006-09 Impact factor: 9.461
Authors: Carine Biallosterski; Mirjam E J van Velthoven; Robert P J Michels; Reinier O Schlingemann; J Hans DeVries; Frank D Verbraak Journal: Br J Ophthalmol Date: 2007-03-23 Impact factor: 4.638
Authors: Mona K Garvin; Michael D Abramoff; Randy Kardon; Stephen R Russell; Xiaodong Wu; Milan Sonka Journal: IEEE Trans Med Imaging Date: 2008-10 Impact factor: 10.048
Authors: C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer Journal: Ophthalmology Date: 2003-09 Impact factor: 12.079
Authors: Adam Hedberg-Buenz; Mark A Christopher; Carly J Lewis; Kimberly A Fernandes; Laura M Dutca; Kai Wang; Todd E Scheetz; Michael D Abràmoff; Richard T Libby; Mona K Garvin; Michael G Anderson Journal: Exp Eye Res Date: 2015-10-22 Impact factor: 3.467
Authors: P Carpineto; L Toto; R Aloia; V Ciciarelli; E Borrelli; E Vitacolonna; M Di Nicola; L Di Antonio; R Mastropasqua Journal: Eye (Lond) Date: 2016-02-12 Impact factor: 3.775
Authors: Nazli Demirkaya; Hille W van Dijk; Sanne M van Schuppen; Michael D Abràmoff; Mona K Garvin; Milan Sonka; Reinier O Schlingemann; Frank D Verbraak Journal: Invest Ophthalmol Vis Sci Date: 2013-07-22 Impact factor: 4.799
Authors: Nicholas C Holoman; Jacob J Aiello; Timothy D Trobenter; Matthew J Tarchick; Michael R Kozlowski; Emily R Makowski; Darryl C De Vivo; Charandeep Singh; Jonathan E Sears; Ivy S Samuels Journal: J Neurosci Date: 2021-02-23 Impact factor: 6.167